Gain Therapeutics, Inc. - COM (GANX)

CUSIP: 36269B105

Q1 2024 13F Holders as of 31 Mar 2024

Share change
+344,896
Put/Call ratio
72%
SEC-reported price per share
$3.77
Number of holders
26
Value change
+$1,318,354
Number of buys
15
Open additional details 1 more signal available
Number of sells
9

Security key

36269B105

Report period

Q1 2024

Institutions

26

Top holders

10

Ownership snapshot

Top reported holders of GANX - Gain Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GREENLIGHT CAPITAL INC
Disclosed value leader
GREENLIGHT CAPITAL INC
Comparable rows
0/15
Latest evidence
26 Mar 2024
13F 3/4/5 Highest disclosed value: $1,921,158 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GREENLIGHT CAPITAL INC has the largest disclosed position value at $1.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GREENLIGHT CAPITAL INC's linked filing trail.
Disclosed position value Top 5
GREENLIGHT CAPITAL INC $1.92M
ROYAL BANK OF CANADA $654K
GEODE CAPITAL MANAGEMENT, LLC $494.6K
CM Management, LLC $293.8K
VANGUARD GROUP INC $288.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GREENLIGHT CAPITAL INC
13F
Company
13F
class O/S missing
$1,921,158
588,410 shares
31 Dec 2023
ROYAL BANK OF CANADA
13F
Company
13F
class O/S missing
$654,000
200,248 shares
31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$494,649
151,476 shares
31 Dec 2023
CM Management, LLC
13F
Company
13F
class O/S missing
$293,850
90,000 shares
31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
class O/S missing
$288,577
88,385 shares
31 Dec 2023
CITADEL ADVISORS LLC
13F
Company
13F
class O/S missing
$213,512
65,394 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
1,867,615
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
26
Q1 2024 holders
26
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .